-
Je něco špatně v tomto záznamu ?
MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions
M. Hlavna, M. Raudenska, K. Hudcova, J. Gumulec, M. Sztalmachova, V. Tanhäuserova, P. Babula, V. Adam, T. Eckschlager, R. Kizek, M. Masarik,
Jazyk angličtina Země Řecko
Typ dokumentu časopisecké články, práce podpořená grantem
NLK
Free Medical Journals
od 2006 do Před 1 rokem
ProQuest Central
od 2012-01-01
Nursing & Allied Health Database (ProQuest)
od 2012-01-01
Health & Medicine (ProQuest)
od 2012-01-01
PubMed
23064315
DOI
10.3892/ijo.2012.1655
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- genetická transkripce účinky léků MeSH
- lidé středního věku MeSH
- lidé MeSH
- messenger RNA genetika MeSH
- mikro RNA genetika MeSH
- nádorové buněčné linie MeSH
- nádory prostaty genetika metabolismus MeSH
- regulace genové exprese u nádorů * účinky léků MeSH
- síran zinečnatý farmakologie MeSH
- zinek metabolismus MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
MicroRNAs (miRNAs) are a large class of single-stranded RNA molecules involved in post-transcriptional gene silencing. miRNAs not only regulate various developmental and physiological processes but also are involved in cancer development. Additionally, they can be considered as biomarkers of some pathological processes. The aim of this study was to determine the expression levels of selected miRNA and zinc(II)-related genes (ZIP-1, BAX, MT2A and MT1A) in the non-tumor PNT1A prostate cell line in comparison with the prostate cancer cell lines 22Rv1, PC-3 and LNCaP after zinc(II) treatment. Using bioinformatic approaches we selected miRNAs with putative binding sites in the 3'UTR regions in Metallothionein 1A and 2A as miRNA 23a, 141, 224, 296-3p, 320, 375 and 376. We observed significantly higher expression of miRNA 23a in all tumor lines compared to non-tumor PNT1A (13.6-fold in 22Rv1, 7.3-fold in PC-3, 8.3-fold in LNCaP, p<0.01). We also observed that the 22Rv1 cell line has significantly higher expression of miRNA 224 in comparison to other cell lines. In addition, all tumor cell lines expressed significantly higher levels of miRNA 375 in comparison to non-tumor PNT1A (87.1‑fold in 22Rv1, nearly 2,000-fold in PC-3, 56.3‑fold in LNCaP, p<0.01). Nevertheless, miRNA 375 and 23a expression levels strongly suggest their potential to contribute to the diagnosis of prostate cancer and miRNA 224 eventually may be suitable for classification of primary tumors. The expression of miRNA 224 in 22Rv1 cell line was negatively correlated with increasing zinc(II) concentration only. Our experiments revealed significant negative correlation of miRNA 376 and MT2A in 22Rv1 and a negative correlation between miRNA 224 and MT1A in PC-3 cells which may denote possible direct regulation of MT genes by specific miRNAs in prostate cancer.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13024249
- 003
- CZ-PrNML
- 005
- 20130710124954.0
- 007
- ta
- 008
- 130703s2012 gr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.3892/ijo.2012.1655 $2 doi
- 035 __
- $a (PubMed)23064315
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gr
- 100 1_
- $a Hlavna, Marian $u Department of Pathological Physiology, Masaryk University, CZ-625 00 Brno, Czech Republic.
- 245 10
- $a MicroRNAs and zinc metabolism-related gene expression in prostate cancer cell lines treated with zinc(II) ions / $c M. Hlavna, M. Raudenska, K. Hudcova, J. Gumulec, M. Sztalmachova, V. Tanhäuserova, P. Babula, V. Adam, T. Eckschlager, R. Kizek, M. Masarik,
- 520 9_
- $a MicroRNAs (miRNAs) are a large class of single-stranded RNA molecules involved in post-transcriptional gene silencing. miRNAs not only regulate various developmental and physiological processes but also are involved in cancer development. Additionally, they can be considered as biomarkers of some pathological processes. The aim of this study was to determine the expression levels of selected miRNA and zinc(II)-related genes (ZIP-1, BAX, MT2A and MT1A) in the non-tumor PNT1A prostate cell line in comparison with the prostate cancer cell lines 22Rv1, PC-3 and LNCaP after zinc(II) treatment. Using bioinformatic approaches we selected miRNAs with putative binding sites in the 3'UTR regions in Metallothionein 1A and 2A as miRNA 23a, 141, 224, 296-3p, 320, 375 and 376. We observed significantly higher expression of miRNA 23a in all tumor lines compared to non-tumor PNT1A (13.6-fold in 22Rv1, 7.3-fold in PC-3, 8.3-fold in LNCaP, p<0.01). We also observed that the 22Rv1 cell line has significantly higher expression of miRNA 224 in comparison to other cell lines. In addition, all tumor cell lines expressed significantly higher levels of miRNA 375 in comparison to non-tumor PNT1A (87.1‑fold in 22Rv1, nearly 2,000-fold in PC-3, 56.3‑fold in LNCaP, p<0.01). Nevertheless, miRNA 375 and 23a expression levels strongly suggest their potential to contribute to the diagnosis of prostate cancer and miRNA 224 eventually may be suitable for classification of primary tumors. The expression of miRNA 224 in 22Rv1 cell line was negatively correlated with increasing zinc(II) concentration only. Our experiments revealed significant negative correlation of miRNA 376 and MT2A in 22Rv1 and a negative correlation between miRNA 224 and MT1A in PC-3 cells which may denote possible direct regulation of MT genes by specific miRNAs in prostate cancer.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a regulace genové exprese u nádorů $x účinky léků $7 D015972
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a mikro RNA $x genetika $7 D035683
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory prostaty $x genetika $x metabolismus $7 D011471
- 650 _2
- $a messenger RNA $x genetika $7 D012333
- 650 _2
- $a genetická transkripce $x účinky léků $7 D014158
- 650 _2
- $a zinek $x metabolismus $7 D015032
- 650 _2
- $a síran zinečnatý $x farmakologie $7 D019287
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Raudenska, Martina $u -
- 700 1_
- $a Hudcova, Kristyna $u -
- 700 1_
- $a Gumulec, Jaromir $u -
- 700 1_
- $a Sztalmachova, Marketa $u -
- 700 1_
- $a Tanhäuserova, Veronika $u -
- 700 1_
- $a Babula, Petr $u -
- 700 1_
- $a Adam, Vojtěch $u - $7 xx0064599
- 700 1_
- $a Eckschlager, Tomas $u -
- 700 1_
- $a Kizek, Rene $u -
- 700 1_
- $a Masarik, Michal $u -
- 773 0_
- $w MED00002350 $t International journal of oncology $x 1791-2423 $g Roč. 41, č. 6 (2012), s. 2237-44
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23064315 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20130703 $b ABA008
- 991 __
- $a 20130710125418 $b ABA008
- 999 __
- $a ok $b bmc $g 987929 $s 822629
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2012 $b 41 $c 6 $d 2237-44 $i 1791-2423 $m International journal of oncology $n Int J Oncol $x MED00002350
- LZP __
- $a Pubmed-20130703